Meeting Coverage > CTAD Omega-3 Supplements Show Benefit in APOE4 Carriers — Trial finds DHA can penetrate the brain before dementia onset. by Judy George, Deputy Managing Editor, MedPage Today ...

New program combines IV-delivered TRACERTM capsid with bifunctional payload to silence APOE in carriers of the high-risk APOE4 variant while delive ...

Massive proteomics database links gene variant APOE 4 to chronic inflammation.

Could early signs of Alzheimer’s disease be found in the brain’s vascular defenses? New research published in Alzheimer’s & ...

In APOE4 carriers, the association of DSC scores with increased exposure to the nine-metal mixture was comparable to a 6-year increase in age, the researchers noted.

Switch Therapeutics Inc. has announced its first development candidate, a liver-sparing APOE (apolipoprotein E) RNAi therapy for treatment of Alzheimer’s disease in APOE4 carriers. Switch’s ...

Switch Therapeutics Inc. has announced its first development candidate, a liver-sparing APOE (apolipoprotein E) RNAi therapy for treatment of Alzheimer’s disease in APOE4 carriers. Switch’s ...